← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 21, 2021Last known activity
Apr 18, 2023
Acquired by Revolution Medicines, Inc. on Nov 9, 2023
Timeline
2010s
- Jun 1, 2019
EQRx, Inc.— Founded
2020s
- Nov 9, 2023
Revolution Medicines, Inc.— Acquired By
Drugs by trial phase (6 distinct, 6 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (6)
- NCT05131438Lead sponsorN/A—
- NCT05712941Lead sponsorPhase 3Apr 18, 2023
- NCT05493501Lead sponsorPhase 3Jul 29, 2022
- NCT05199610Lead sponsorPhase 1Mar 22, 2022
- NCT05085002Lead sponsorPhase 2Nov 30, 2021
- NCT04969965Lead sponsorPhase 1Jun 21, 2021
Details
- Founded
- Cambridge, MA, US Jun 1, 2019
- Last known activity
- Apr 18, 2023